Terns Pharmaceuticals Inc. buy BiotechBee
Start price
22.06.24
/
50%
€6.85
Target price
30.04.26
€10.00
Performance (%)
16.79%
Price
22.07.24
€7.70
Summary
This prediction is currently active. The prediction currently has a performance of 16.79%. This prediction currently runs until 30.04.26. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Terns Pharmaceuticals Inc. | -13.736% | -13.736% |
iShares Core DAX® | -0.543% | 1.491% |
iShares Nasdaq 100 | -2.696% | -1.235% |
iShares Nikkei 225® | -2.863% | 2.491% |
iShares S&P 500 | -1.105% | 0.013% |
According to BiotechBee what are the pros and cons of Terns Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Terns Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 10,0
Stopped prediction by BiotechBee for Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.87
24.06.23
24.06.23
€18.00
31.12.25
31.12.25
-45.26%
01.10.23
01.10.23
Could be very worthwhile Investment >20% year